SCHEMBL188646

SCHEMBL188646

COc1ccc(COc2cccc(F)c2C#N)cc1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 2/20 0.59
RAB9A P51151 2/20 0.59
MAOB P27338 3/20 0.48
ABCB1 P08183 2/20 0.47
ALDH1A1 P00352 2/20 0.46
MAPT P10636 2/20 0.46
HPGD P15428 2/20 0.46
TSHR P16473 1/20 0.46
CASP1 P29466 1/20 0.46
HTR1A P08908 1/20 0.45
ADRA1D P25100 1/20 0.45
ADRA1A P35348 1/20 0.45
ADRA1B P35368 1/20 0.45
LMNA P02545 1/20 0.44
GAA P10253 1/20 0.44
SGMS2 Q8NHU3 1/20 0.44
CYP2D6 P10635 2/20 0.44
ADRB2 P07550 1/20 0.44
SLC6A2 P23975 1/20 0.44
SLC6A4 P31645 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1155271 0.87 NPC1 (0.55) NPC1RAB9AMAOBALDH1A1MAPT
SCHEMBL1154479 0.86 NPC1 (0.55) NPC1RAB9AMAOBALDH1A1MAPT
SCHEMBL646003 0.84 NPC1 (0.51) NPC1RAB9AMAOBALDH1A1MAPT
SCHEMBL1154614 0.84 NPC1 (0.56) NPC1RAB9AABCB1ALDH1A1MAPT
SCHEMBL2414580 0.83 NPC1 (0.59) NPC1RAB9AMAOBABCB1ALDH1A1
SCHEMBL1154971 0.83 NPC1 (0.51) NPC1RAB9AAPPMEN1KMT2A
SCHEMBL1154249 0.83 NPC1 (0.70) NPC1RAB9AMAOBMAPTHTR1A
SCHEMBL1155280 0.83 NPC1 (0.51) NPC1RAB9AMAOBHTTMEN1
SCHEMBL31496881 0.81 NPC1 (0.50) NPC1RAB9AMAOBABCB1APP
SCHEMBL22169453 0.81 POLB (0.57) NPC1RAB9AALDH1A1MAPTHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8288396-B2 Pyrimidopyrimidoindazole derivative MSDKK (JP) 2012-10-16 US disclosed
US-20120134955-A1 PYRIMIDOPYRIMIDOINDAZOLE DERIVATIVE MSD K.K. (JP) 2012-05-31 US disclosed
EP-2401281-A1 PYRIMIDOPYRIMIDOINDAZOLE DERIVATIVE MSD K.K. (JP) 2012-01-04 EP disclosed
WO-2010098367-A1 PYRIMIDOPYRIMIDOINDAZOLE DERIVATIVE BANYU PHARMACEUTICAL CO.,LTD. (JP) 2010-09-02 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120134955-A1 PYRIMIDOPYRIMIDOINDAZOLE DERIVATIVE WEE1, WEE2, DCK NPC1 4341/4885RAB9A 2226/4885MAOB 563/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.